mPharma’s Independent Impact Assessment Report in Collaboration With 60 Decibels: Our Drive Towards Improving The Value We Provide to Patients.

We are excited to announce that 60 Decibels concluded our second independent impact assessment focusing on Nigeria. This was made possible by a grant from British International Investment, a shareholder of mPharma.

Access the report here